Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Mimedx (MDXG) over the last 13 years, with Q3 2025 value amounting to 0.17%.

  • Mimedx's Return on Invested Capital fell 3400.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year decrease of 3400.0%. This contributed to the annual value of 0.21% for FY2024, which is 5200.0% down from last year.
  • As of Q3 2025, Mimedx's Return on Invested Capital stood at 0.17%, which was down 3400.0% from 0.15% recorded in Q2 2025.
  • Mimedx's Return on Invested Capital's 5-year high stood at 0.74% during Q3 2023, with a 5-year trough of 0.85% in Q1 2021.
  • For the 5-year period, Mimedx's Return on Invested Capital averaged around 0.02%, with its median value being 0.15% (2025).
  • As far as peak fluctuations go, Mimedx's Return on Invested Capital plummeted by -7200bps in 2021, and later soared by 15200bps in 2023.
  • Quarter analysis of 5 years shows Mimedx's Return on Invested Capital stood at 0.16% in 2021, then crashed by -221bps to 0.5% in 2022, then soared by 235bps to 0.67% in 2023, then plummeted by -68bps to 0.22% in 2024, then decreased by -21bps to 0.17% in 2025.
  • Its Return on Invested Capital was 0.17% in Q3 2025, compared to 0.15% in Q2 2025 and 0.19% in Q1 2025.